![Kory Wentworth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kory Wentworth
Director of Finance/CFO at
ENTRADA THERAPEUTICS, INC.
Net worth: 102 760 $ as of 30/07/2026
Profile
Kory James Wentworth is Chief Financial Officer & Treasurer at Entrada Therapeutics, Inc. since 2020.
Former positions include Treasurer & Vice President-Finance at Genetix Biotherapeutics, Inc. from 2017 to 2020, Executive Director & Corporate Controller at Alexion Pharmaceuticals, Inc. in 2017, and Audit Manager at PricewaterhouseCoopers LLP from 2002 to 2008.
Education includes undergraduate studies at Susquehanna University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/04/2026 | 15,134 ( 0.04% ) | 102 760 $ | 30/07/2026 |
Kory Wentworth active positions
| Companies | Position | Start |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Director of Finance/CFO | 31/10/2020 |
Former positions of Kory Wentworth
| Companies | Position | End |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Comptroller/Controller/Auditor | 07/09/2020 |
| ALEXION PHARMACEUTICALS, INC. | Director/Board Member | 30/11/2017 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Comptroller/Controller/Auditor | 30/11/2008 |
Training of Kory Wentworth
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
98
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Susquehanna University
 Susquehanna University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
- Stock Market
- Insiders
- Kory Wentworth
